2009, Number 1
<< Back Next >>
salud publica mex 2009; 51 (1)
Association between the TaqI polymorphism of Vitamin D Receptor gene and lepromatous leprosy in a Mexican population sample
Velarde FJS, Cázarez SSG, Castro VR, Rendón MJG, Rangel VH
Language: Spanish
References: 16
Page: 59-61
PDF size: 192.81 Kb.
ABSTRACT
Objetive. To establish the association of the vitamin D receptor gene TaqI polymorphism with lepromatous leprosy (LL) in individuals from Sinaloa, Mexico.
Material and Methods. A 740 bp fragment was amplified from the VDR gene in DNA samples of 71 patients with LL and 144 controls in the Hospital General de Culiacán during 2004-2007. Polymorphism was identified through TaqI endonuclease.
Results. A significant increase in the genotype TT of the VDR gene was observed in patients when compared to controls (p = 0.040; OR = 1.82).
Conclusions. Our data support the association between the TT genotype and susceptibility to LL in this Mexican population.
REFERENCES
López-Antuñano F. Diagnóstico y tratamiento de la lepra. Salud Publica Mex 1998;40:1-10.
Eden W, Gonzalez NM, de Vries RR, Convit J, van Rood JJ. HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis 1985; 151:9-14.
Anuario de Morbilidad 2007. Sistema Único de Información Epidemiológica. México: Secretaría de Salud, Dirección General de Epidemiología, 2007.
Gorodezky C, Flores J, Arevalo N, Castro LE, Silva A, Rodriguez O. Tuberculoid leprosy in mexicans is associated with HLA-DR3. Lepr Rev 1987; 58: 401-406.
Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 1996;56:4108-4110.
Seyhan S, Javascaoglu I, Kilickrslan H, Dogan HS, Kordan Y. Association of vitamin D receptor gene TaqI polymorphism with recurrent urolithiasis in children. Int J Urol 2007;14:1060-1062.
Hill AV. Aspects of genetic susceptibility to human infectious diseases. Annu Rev Genet 2006;40:469-486.
Roy S, Frodsham A, Saha B, Hazra SK, Mascie-Taylor CG, Hill AV. Association of vitamin D receptor genotype with leprosy type. J Infect Dis 1999;179:187-191.
Fitness J, Floyd S, Warndorff DK, Sichali L, Mwaungulu L, Crampin AC, et al. Large-scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg 2004;71:330-340.
Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966;34:255-273.
Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991;11:298-302.
Bornman L, Campbell SJ, Fielding K, Bah B, Sillah J, Gustafson P, et al. Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J Infect Dis 2004;190: 1631-1641.
Rigby WF. The immunobiology of vitamin D. Immunol Today 1988;9:54-58.
Gelder CM, Hart KW, Williams OM, Lyons E, Welsh KI, Campbell IA, et al. Vitamin D receptor gene polymorphisms and susceptibility to Mycobacterium malmoense pulmonary disease. J Infect Dis 2000;181:2099-2102.
Selvaraj P, Chandra G, Jawahar MS, Rani MV, Rajeshwari DN, Narayanan PR. Regulatory role of vitamin D receptor gene variants of BsmI, ApaI, TaqI, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. J Clin Immunol 2004;24:523-532.
Rook GA, Steele J, Fraher L, Barker S, Karmali R, O’Riordan J, et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986;57:159-163.